David Katz - Matrix Asset Advisors Inc
Holding/activity history for Sorrento Therapeutics, Inc. (SRNE)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2020 Q3 | 0 | 0.00 | Sell 100.00% | 0.06 | SEC | ||
| 2020 Q2 | 50,000 | 0.06 | $6.28 | $314,000 | SEC | ||
| 2020 Q1 | 50,000 | 0.02 | $1.84 | $92,000 | SEC | ||
| 2019 Q4 | 50,000 | 0.03 | Reduce 16.67% | <0.01 | $3.38 | $169,000 | SEC |
| 2019 Q3 | 60,000 | 0.02 | $2.13 | $128,000 | SEC | ||
| 2019 Q2 | 60,000 | 0.03 | $2.67 | $160,000 | SEC | ||
| 2019 Q1 | 60,000 | 0.05 | $4.75 | $285,000 | SEC | ||
| 2018 Q4 | 60,000 | 0.03 | $2.40 | $144,000 | SEC | ||
| 2018 Q3 | 60,000 | 0.04 | $4.40 | $264,000 | SEC | ||
| 2018 Q2 | 60,000 | 0.07 | Add 20.00% | 0.01 | $7.20 | $432,000 | SEC |
| 2018 Q1 | 50,000 | 0.04 | Reduce 30.56% | 0.01 | $5.16 | $258,000 | SEC |
| 2017 Q4 | 72,000 | 0.04 | $3.81 | $274,000 | SEC | ||
| 2017 Q3 | 72,000 | 0.02 | $1.69 | $122,000 | SEC | ||
| 2017 Q2 | 72,000 | 0.02 | Add 227.27% | 0.01 | $2.00 | $144,000 | SEC |
| 2017 Q1 | 22,000 | 0.02 | $3.95 | $87,000 | SEC | ||
| 2016 Q4 | 22,000 | 0.02 | Reduce 4.88% | <0.01 | $4.91 | $108,000 | SEC |
| 2016 Q3 | 23,128 | 0.03 | $7.74 | $179,000 | SEC | ||
| 2016 Q2 | 23,128 | 0.03 | $5.62 | $130,000 | SEC | ||
| 2016 Q1 | 23,128 | 0.02 | $5.36 | $124,000 | SEC | ||
| 2015 Q4 | 23,128 | 0.04 | $8.69 | $201,000 | SEC | ||
| 2015 Q3 | 23,128 | 0.03 | $8.39 | $194,000 | SEC | ||
| 2015 Q2 | 23,128 | 0.05 | $17.64 | $408,000 | SEC | ||
| 2015 Q1 | 23,128 | 0.03 | $11.54 | $267,000 | SEC | ||
| 2014 Q4 | 23,128 | 0.03 | $10.07 | $233,000 | SEC | ||
| 2014 Q3 | 23,128 | 0.01 | $4.54 | $105,000 | SEC | ||
| 2014 Q2 | 23,128 | 0.02 | $6.75 | $156,000 | SEC | ||
| 2014 Q1 | 23,128 | 0.04 | $12.84 | $297,000 | SEC | ||
| 2013 Q4 | 23,128 | 0.02 | Reduce 6.09% | <0.01 | $8.09 | $187,000 | SEC |
| 2013 Q3 | 24,628 | 0.03 | Buy | 0.03 | $9.58 | $236,000 | SEC |